Ultrasound in the diagnosis and management of giant cell arteritis

Rheumatology (United Kingdom)

Volumn 57, Issue , 2018, Pages ii22-ii31

  Schmidt, Wolfgang A ^a  

^a MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

Giant cell arteritis; Large vessel vasculitis; Polymyalgia rheumatica; Takayasu arteritis; Ultrasound

Indexed keywords

AORTA; ARTICLE; AXILLARY ARTERY; CAROTID ARTERY; CLINICAL PRACTICE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; FEMORAL ARTERY; GIANT CELL ARTERITIS; HUMAN; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL ARTERY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RELIABILITY; SUBCLAVIAN ARTERY; TEMPORAL ARTERY; ULTRASOUND; VERTEBRAL ARTERY; BIOPSY; DIAGNOSTIC IMAGING; ECHOGRAPHY; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; RHEUMATOLOGY; SENSITIVITY AND SPECIFICITY; STATISTICS AND NUMERICAL DATA;

BIOPSY; GIANT CELL ARTERITIS; HUMANS; REPRODUCIBILITY OF RESULTS; RHEUMATOLOGY; SENSITIVITY AND SPECIFICITY; TEMPORAL ARTERIES; ULTRASONOGRAPHY;

EID: 85042609531     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kex461     Document Type: Article

References (65)

1. Bley TA, Reinhard M, Hauenstein C et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum 2008;58:2574-8.
2. Luqmani R, Lee E, Singh S et al. The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 2016;20:1-238.
3. Schmidt WA. Role of ultrasound in the understanding and management of vasculitis. Ther Adv Musculoskelet Dis 2014;6:39-47.
4. Czihal M, Lottspeich C, Hoffmann U. Ultrasound imaging in the diagnosis of large vessel vasculitis. Vasa 2017;46:241-53.
5. Muratore F, Pipitone N, Salvarani C, Schmidt WA. Imaging of vasculitis: state of the art. Best Pract Res Clin Rheumatol 2016;30:688-706.
6. Duftner C, Dejaco C, Moller-Dohn U. Ultrasound definitions for vasculitis in cranial and large vessel giant cell arteritis: results of a Delphi survey of the OMERACT ultrasound large vessel vasculitis group. Ann Rheum Dis 2016;75(Suppl 2):626. Doi: 10.1136/annrheumdis-2016- eular.5487
7. Schmidt WA, Kraft HE, Volker L, Vorpahl K, Gromnica-Ihle EJ. Colour Doppler sonography to diagnose temporal arteritis. Lancet 1995;345:866
8. de Miguel E,Roxo A, Castillo Cet al. The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis. Clin Exp Rheumatol 2012;30(1 Suppl 70):S34-8.
9. Salvarani C, Silingardi M, Ghirarduzzi A et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis? Ann Intern Med 2002;137:232-8.
10. Forster S, Tato F, Weiss M et al. Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET. Vasa 2011;40:219-27.
11. Czihal M, Schrottle A, Baustel K et al. B-mode sonography wall thickness assessment of the temporal and axillary arteries for the diagnosis of giant cell arteritis: a cohort study. Clin Exp Rheumatol 2017;35(Suppl 103):128-33.
12. Schäfer VS, Juche A, Ramiro S, Krause A, Schmidt WA. Ultrasound cut-off values for intima-media thickness of temporal, facial and axillary arteries in giant cell arteritis. Rheumatology 2017;56:1479-83.
13. Aschwanden M, Daikeler T, Kesten F et al. Temporal artery compression sign-a novel ultrasound finding for the diagnosis of giant cell arteritis. Ultraschall Med 2013;34:47-50.
14. Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997;337:1336-42.
15. Brack A, Martinez-Taboada V, Stanson A, Goronzy JJ, Weyand CM. Disease pattern in cranial and large-vessel giant cell arteritis. Arthritis Rheum 1999;42:311-7.
16. Schmidt WA, Seifert A, Gromnica-Ihle E, Krause A, Natusch A. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology 2008;47:96-101.
17. Schmidt WA, Moll A, Seifert A et al. Prognosis of large-vessel giant cell arteritis. Rheumatology 2008;47:1406-8.
18. Kermani TA, Warrington KJ, Crowson CS et al. Largevessel involvement in giant cell arteritis: a populationbased cohort study of the incidence-trends and prognosis. Ann Rheum Dis 2013;72:1989-94.
19. Muratore F, Kermani TA, Crowson CS et al. Large-vessel giant cell arteritis: a cohort study. Rheumatology 2015;54:463-70.
20. Czihal M, Piller A, Schroettle A et al. Impact of cranial and axillary/subclavian artery involvement by color duplex sonography on response to treatment in giant cell arteritis. J Vasc Surg 2015;61:1285-91.
21. Jese R, Rotar Z, Tomsic M, Hocevar A. The role of colour Doppler ultrasonography of facial and occipital arteries in patients with giant cell arteritis: a prospective study. Eur J Radiol 2017;95:9-12.
22. Monti S, Floris A, Ponte C et al. The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist. Rheumatology 2018;57:227-35.
23. Roncato C, Allix-Beguec C, Brottier-Mancini E, Gombert B, Denis G. Diagnostic performance of color duplex ultrasonography along with temporal artery biopsy in suspicion of giant cell arteritis. Clin Exp Rheumatol 2018;35(Suppl 103):119-22.
24. Croft AP, Thompson N, Duddy MJ et al. Cranial ultrasound for the diagnosis of giant cell arteritis. A retrospective cohort study. J R Coll Physicians Edinb 2015;45:268-72.
25. Cristaudo AT, Mizumoto R, Hendahewa R. The impact of temporal artery biopsy on surgical practice. Ann Med Surg 2016;11:47-51.
26. Duftner C, Dejaco C, Sepriano A, et al. Imaging in diagnosis, outcome prediction and monitoring of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations. RMD Open (in press).
27. Ball EL, Walsh SR, Tang TY, Gohil R, Clarke JM. Role of ultrasonography in the diagnosis of temporal arteritis. Br J Surg 2010;97:1765-71.
28. Arida A, Kyprianou M, Kanakis M, Sfikakis PP. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord 2010;11:44.
29. Karassa FB, Matsagas MI, Schmidt WA, Ioannidis JP. Meta-analysis: test performance of ultrasonography for giant-cell arteritis. Ann Intern Med 2005;142:359-69.
30. Diamantopoulos AP, Haugeberg G, Hetland H et al. Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res 2014;66:113-9.
31. Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA 2016;315:2442-58.
32. Dejaco C, Duftner C, Buttgereit F, Matteson EL, Dasgupta B. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology 2017;56:506-15.
33. Aranda-Valera IC, Garcia Carazo S, Monjo Henry I, de Miguel Mendieta E. Diagnostic validity of Doppler ultrasound in giant cell arteritis. Clin Exp Rheumatol 2017;35(Suppl 103):123-7.
34. de Miguel E, Castillo C, Rodriguez A, de Agustin JJ. Learning and reliability of colour Doppler ultrasound in giant cell arteritis. Clin Exp Rheumatol 2009;27(1 Suppl 52):S53-8.
35. Aschwanden M, Imfeld S, Staub D et al. The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement. Clin Exp Rheumatol 2015;33(Suppl 89):S-113-5.
36. Chrysidis S, Duftner C, Dejaco C et al. Ultrasound definitions for cranial and large vessel giant cell arteritis: results of a reliability exercise on images and videos of the OMERACT ultrasound large vessel vasculitis task force. Arthritis Rheumatol 2016;68 (suppl 10).
37. Bruyn GA, Naredo E, Iagnocco A et al. The OMERACT Ultrasound Working Group 10 years on: update at OMERACT 12. J Rheumatol 2015;42:2172-6.
38. Terslev L, Iagnocco A, Bruyn GA et al. The OMERACT Ultrasound Group: a report from the OMERACT 2016 meeting and perspectives. J Rheumatol 2017;44:1740-3.
39. Gutierrez M, Schmidt WA, Thiele RG et al. International Consensus for ultrasound lesions in gout: results of Delphi process and web-reliability exercise. Rheumatology 2015;54:1797-805.
40. Filippou G, Scire CA, Damjanov N et al. Definition and reliability assessment of elementary ultrasonographic findings in calcium pyrophosphate deposition disease: a study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force. J Rheumatol 2017; 44:1744-9.
41. Terslev L, Gutierrez M, Christensen R et al. Assessing elementary lesions in gout by ultrasound: results of an OMERACT patient-based agreement and reliability exercise. J Rheumatol 2015;42:2149-54.
42. Schäfer VS, Chrysidis S, Dejaco C et al. A patient based reliability exercise of Omeract ultrasound definitions in giant cell arteritis. Arthritis Rheumatol 2017;69 (suppl 10).
43. Germano G, Monti S, Ponte C et al. The role of ultrasound in the diagnosis and follow-up of large-vessel vasculitis: an update. Clin Exp Rheumatol 2017;35(Suppl 103):194-8.
44. Germano G, Muratore F, Cimino L et al. Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis? A randomized study. Rheumatology 2015;54:400-4.
45. Muratore F, Boiardi L, Restuccia G et al. Comparison between colour duplex sonography findings and different histological patterns of temporal artery. Rheumatology 2013;52:2268-74.
46. Seeliger B, Sznajd J, Robson JC et al. Are the 1990 American College of Rheumatology vasculitis classification criteria still valid? Rheumatology 2017;56:1154-61.
47. Czihal M, Tato F, Forster S et al. Fever of unknown origin as initial manifestation of large vessel giant cell arteritis: diagnosis by colour-coded sonography and 18-FDG-PET. Clin Exp Rheumatol 2010;28:549-52.
48. Pfadenhauer K, Rull T. Ultrasonographic and FDG-PET imaging in active giant cell arteritis of the carotid arteries. Vasa 2005;34:269-71.
49. Germano G, Macchioni P, Possemato N et al. Contrastenhanced ultrasound of the carotid artery in patients with large vessel vasculitis: correlation with positron emission tomography findings. Arthritis Care Res 2017;69:143-9.
50. Terslev L, Hammer HB, Torp-Pedersen S et al. EFSUMB minimum training requirements for rheumatologists performing musculoskeletal ultrasound. Ultraschall Med 2013;34:475-7.
51. Santoro L, D'Onofrio F, Bernardi S et al. Temporal ultrasonography findings in temporal arteritis: early disappearance of halo sign after only 2 days of steroid treatment. Rheumatology 2013;52:622.
52. Hauenstein C, Reinhard M, Geiger J et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology 2012;51:1999-2003.
53. Prieto-Gonzalez S, Depetris M, Garcia-Martinez A et al. Positron emission tomography assessment of large vessel inflammation in patients with newly diagnosed, biopsyproven giant cell arteritis: a prospective, case-control study. Ann Rheum Dis 2014;73:1388-92.
54. Khan A, Dasgupta B. Imaging in giant cell arteritis. Curr Rheumatol Rep 2015;17:52.
55. Maleszewski JJ, Younge BR, Fritzlen JT et al. Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients. Mod Pathol 2017;30:788-96.
56. Patil P, Williams M, Maw WW et al. Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol 2015;33(Suppl 89):S-103-6.
57. Diamantopoulos AP, Haugeberg G, Lindland A, Myklebust G. The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis? Rheumatology 2016;55:66-70.
58. Alberts M. Temporal arteritis: improving patient evaluation with a new protocol. Perm J 2013;17:56-62.
59. Schmidt WA, Krause A, Schicke B, Kuchenbecker J, Gromnica-Ihle E. Do temporal artery duplex ultrasound findings correlate with ophthalmic complications in giant cell arteritis? Rheumatology 2009;48:383-5.
60. Dasgupta B, Cimmino MA, Maradit-Kremers H et al. 2012 provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 2012;71:484-92.
61. Macchioni P, Boiardi L, Catanoso M, Pazzola G, Salvarani C. Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis 2014;73:1190-3.
62. Mackie SL, Koduri G, Hill CL et al. Accuracy of musculoskeletal imaging for the diagnosis of polymyalgia rheumatica: systematic review. RMD Open 2015;1:e000100.
63. Laria A, Lurati A, Scarpellini M. Color duplex ultrasonography findings of temporal arteries in a case of giant cell arteritis: role in diagnosis and follow-up. Open Access Rheumatol 2017;9:55-9.
64. Habib HM, Essa AA, Hassan AA. Color duplex ultrasonography of temporal arteries: role in diagnosis and followup of suspected cases of temporal arteritis. Clin Rheumatol 2012;31:231-7.
65. Stone JH, Tuckwell K, Dimonaco S et al. Trial of tocilizumab in giant-cell arteritis. N Engl J Med 2017;377:317-28.